Zdrowie i gospodarka · 19/03/2009

FDA Approves Supplemental New Animal Drug Application for Tylosin Injectable Solution

The US Food and Drug Administration (FDA) is updating its regulations to reflect the approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, which allows for changes to the labeling of tylosin injectable solution to include a new scientific nomenclature for a bovine pathogen.